BEN-NOON ALON enters NEUROSENSE THERAPEUTICS LTD. with 4.18M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/30/2026ACC: 0001213900-26-036025
Officer10% Owner· Chief Executive Officer
Since Mar 2026
4.18M
Baseline shares
100% direct
4.18M
Direct ownership
3 positions
106.67K
Derivative underlying
2 instruments
3
Security positions
All direct
Non-Derivative Holdings3
Ordinary Shares
DirectShares owned360.78K
Ordinary Shares
DirectShares owned3.18M
Ordinary Shares
DirectShares owned641.52K
Total
4.18M direct4.18M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 360.78K | Direct |
| Ordinary Shares | 3.18M | Direct |
| Ordinary Shares | 641.52K | Direct |
| Total | 4.18M | 4.18M direct |
Derivative Holdings2
Warrants to purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
26.67K
Shares owned
N/A
Exercise price
0.75
Expiration
—
Exercise window
—
Warrants to purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
80K
Shares owned
N/A
Exercise price
1.25
Expiration
—
Exercise window
—
Total
Underlying
106.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to purchase Ordinary Shares Direct | Ordinary Shares | 0.75 | — | — | 26.67K | N/A |
| Warrants to purchase Ordinary Shares Direct | Ordinary Shares | 1.25 | — | — | 80K | N/A |
| Total | 106.67K | 0.00 | ||||